Therapeutic cocktails for rheumatoid arthritis: The mixmaster's guide

被引:6
作者
Cronstein, BN [1 ]
机构
[1] NYU, Sch Med, New York, NY 10016 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 07期
关键词
D O I
10.1002/art.20374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2041 / 2043
页数:3
相关论文
共 16 条
[1]   THE ANTIINFLAMMATORY MECHANISM OF METHOTREXATE - INCREASED ADENOSINE RELEASE AT INFLAMED SITES DIMINISHES LEUKOCYTE ACCUMULATION IN AN IN-VIVO MODEL OF INFLAMMATION [J].
CRONSTEIN, BN ;
NAIME, D ;
OSTAD, E .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2675-2682
[2]   AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
FURST, D ;
GOLDSMITH, C ;
KATZ, LM ;
LIGHTFOOT, R ;
PAULUS, H ;
STRAND, V ;
TUGWELL, P ;
WEINBLATT, M ;
WILLIAMS, HJ ;
WOLFE, F ;
KIESZAK, S .
ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735
[3]  
Gadangi P, 1996, J IMMUNOL, V156, P1937
[4]   Sulfasalazine is a potent inhibitor of the reduced folate carrier - Implications for combination therapies with methotrexate in rheumatoid arthritis [J].
Jansen, G ;
van der Heijden, J ;
Oerlemans, R ;
Lems, WF ;
Ifergan, I ;
Scheper, RJ ;
Assaraf, YG ;
Dijkmans, BAC .
ARTHRITIS AND RHEUMATISM, 2004, 50 (07) :2130-2139
[5]   Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage [J].
Lard, LR ;
Boers, M ;
Verhoeven, A ;
Vos, K ;
Visser, H ;
Hazes, JMW ;
Zwinderman, AH ;
Schreuder, GMT ;
Breedveld, FC ;
de Vries, RRP ;
van der Linden, S ;
Zanelli, E ;
Huizinga, TWJ .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :899-905
[6]  
Montesinos MC, 2000, ARTHRITIS RHEUM, V43, P656, DOI 10.1002/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO
[7]  
2-H
[8]   Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68 [J].
Montesinos, MC ;
Desai, A ;
Delano, D ;
Chen, JF ;
Fink, JS ;
Jacobson, MA ;
Cronstein, BN .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :240-247
[9]   Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides [J].
Morabito, L ;
Montesinos, MC ;
Schreibman, DM ;
Balter, L ;
Thompson, LF ;
Resta, R ;
Carlin, G ;
Huie, MA ;
Cronstein, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :295-300
[10]  
O'Dell J, 2001, J RHEUMATOL, V28, P21